Prognosis: Intracellular dehydration is the major risk in case of a po
lyuropolydipsic syndrome. Excepting osmotic polyuria, prognosis depend
s on a possibly progressive functional anomaly of the hypothalamopitui
tary axis. Pathophysiology: Polyuropolydipsia occurs when antidiuretic
hormone (ADH) secretion is absent (central diabetes insipidis), the k
idney does not respond to ADH (nephrogenic diabetes insipidus) or in c
ase of physiological inhibition of ADH secretion (primary polydipsia).
Exploration: Dynamic explorations are associated with radioimmunoassa
y of ADH. They are particularly useful in case of atypical diabetes in
sipidus and include the water restriction test and a study of the sens
itivity to exogenous ADH (dDAVP). The results orient the etiologic dia
gnosis and allow an evaluation of the fluid intake required as a funct
ion of the maximal concentrating capacity of the kidneys. Treatment of
central diabetes insipidus: Treatment is based on ADH analogs (dDAVP)
. The aim is to obtain a constant antidiuretic effect without hyponatr
emia or escape. In case oi partial central diabetes insipidus, a non-h
ormone treatment using compounds which increase vasopressin release or
its effect on the kidney can be proposed.